Role of Investing in Human Resources in Enhancing the Organizational Renewal Capabilities of the Pharmaceutical Industry

Sanaa Mostafa  Mohammed; Badreldin Mohamed  Ahmed Abdulrahman; Mohammed Thani  Alhumaid; Mastora Sahal  Gomaa Sahal; Ayman Abdalla  Mohammed Abubakr

doi:10.36941/ajis-2024-0185

Authors

Sanaa Mostafa Mohammed Department of Business Administration, College of Business, Jouf University, Sakaka, Saudi Arabia
Badreldin Mohamed Ahmed Abdulrahman Department of Business Administration, College of Business, Jouf University, Sakaka, Saudi Arabia
Mohammed Thani Alhumaid Department of Business Administration, College of Business, Jouf University, Sakaka, Saudi Arabia
Mastora Sahal Gomaa Sahal Department of Academic Programs for Military Colleges, Abu Dhabi University, United Arab Emirates
Ayman Abdalla Mohammed Abubakr Department of Academic Programs for Military Colleges, Abu Dhabi University, United Arab Emirates

DOI:

https://doi.org/10.36941/ajis-2024-0185

Keywords:

Investing in human resources, organizational renewal capabilities, strategic competence, learning orientation connectivity, leadership behaviors, exploiting time

Abstract

This study aims to explore the role of the dimensions investing in human resources in enhancing the organizational renewal capabilities of companies operating in the pharmaceutical industry. An online survey was conducted among a sample of (350) individuals who worked in pharmaceutical companies in the Kingdom of Saudi Arabia. The results indicate that the dimensions of investing in human resources as assessed by employees of pharmaceutical companies positively enhance all four studied dimensions of organizational renewal capabilities (strategic competence, learning orientation connectivity, leadership practices, exploiting time) for a wide range of pharmaceutical companies. The results confirm that enhancing the investing in human resources is a promising path toward improving the regulatory renewal capabilities of pharmaceutical companies. Despite the interest in investing in human resources, the lack of consensus on the specific elements of investing in human capital limits the understanding of their implications. Building on recent developments in visualizing and measuring investing in human resources, this study addresses this gap by exploring how the investing in human resources relates to the regulatory renewal capabilities of pharmaceutical companies.

Received: 25 August 2024 / Accepted: 30 October 2024 / Published: 05 November 2024